Presbyopia is a common variant of farsightedness affecting over 128 million people in the US, including the majority of ...

The Food and Drug Administration has approved the first aceclidine-based eye drop designed to improve near vision in adults ...

The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million ...

The US Food and Drug Administration has approved the first eye drop that can fix near vision, promising to help people ditch their reading glasses or contact lenses for up to 10 hours at a time.Known ...

For two decades, I had to douse my eyes with artificial tears to get through the day. Then I decided to see if I could shop ...

FDA approval was based on data from phase 3 trials showing significant tear production increase as early as day 1.

Management of glaucoma is evolving beyond eye drops. Explore how tech is helping reshape modern glaucoma treatments today!

Tixel i, an FDA-cleared treatment, utilizes gentle Thermo-Mechanical Action® to apply heat and pressure directly to the meibomian glands, enhancing oil secretion and targeting the root cause of dry ...

The most common adverse reaction reported in clinical trials was instillation site pain (50%). The recommended dose of Tryptyr is 1 drop in each eye twice daily (approximately 12 hours apart).

In June 2025, Bausch + Lomb launched LUMIFY Preservative Free eye drops in the U.S. For more information on the LUMIFY brand, visit www.lumifyeyes.com. About Bausch + Lomb ...